| Year |
Citation |
Score |
| 2023 |
Jensen RA, Befort CA. Cancer Prevention Perspective: The University of Kansas Cancer Center. Cancer Prevention Research (Philadelphia, Pa.). 16: 643-647. PMID 38037383 DOI: 10.1158/1940-6207.CAPR-22-0418 |
0.312 |
|
| 2023 |
Li L, Jensen RA. Understanding and Overcoming Immunosuppression Shaped by Cancer Stem Cells. Cancer Research. 83: 2096-2104. PMID 37403628 DOI: 10.1158/0008-5472.CAN-23-0230 |
0.308 |
|
| 2022 |
Cloud AS, Vargheese AM, Gunewardena S, Shimak RM, Ganeshkumar S, Kumaraswamy E, Jensen RA, Chennathukuzhi VM. Loss of REST in breast cancer promotes tumor progression through estrogen sensitization, MMP24 and CEMIP overexpression. Bmc Cancer. 22: 180. PMID 35177031 DOI: 10.1186/s12885-022-09280-2 |
0.413 |
|
| 2022 |
Bhatti S, Heldstab J, Lehn C, Tawfik O, Ash RM, Hout DR, Seitz RS, Bailey DB, O'Dea AP, Jensen RA, Fan F, Khan QJ, Godwin AK, Sharma P. Clinical Activity of Pembrolizumab in a Patient With Metastatic Triple-Negative Breast Cancer Without Tumor Programmed Death-Ligand 1 Expression: A Case Report and Correlative Biomarker Analysis. Jco Precision Oncology. 1: 1-6. PMID 35172501 DOI: 10.1200/PO.17.00032 |
0.319 |
|
| 2021 |
Subramaniam D, Ponnurangam S, Ramalingam S, Kwatra D, Dandawate P, Weir SJ, Umar S, Jensen RA, Anant S. Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis. Cells. 10. PMID 34206989 DOI: 10.3390/cells10071607 |
0.305 |
|
| 2021 |
Ramamoorthy P, Dandawate P, Jensen RA, Anant S. Celastrol and Triptolide Suppress Stemness in Triple Negative Breast Cancer: Notch as a Therapeutic Target for Stem Cells. Biomedicines. 9. PMID 33924995 DOI: 10.3390/biomedicines9050482 |
0.37 |
|
| 2020 |
Mudaranthakam DP, Harlan-Williams LM, Jensen RA, Kuo H, Garimella V, Chen RC, Mayo MS, Krebill H. OPTIK: a database for understanding catchment areas to guide mobilization of cancer center assets. Database : the Journal of Biological Databases and Curation. 2020. PMID 32719846 DOI: 10.1093/Database/Baaa054 |
0.375 |
|
| 2020 |
Dandawate P, Subramaniam D, Panovich P, Standing D, Krishnamachary B, Kaushik G, Thomas SM, Dhar A, Weir SJ, Jensen RA, Anant S. Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway. Scientific Reports. 10: 1290. PMID 31992775 DOI: 10.1038/S41598-020-57940-9 |
0.353 |
|
| 2020 |
Jensen RA, Knudsen KE, Platanias LC. Disclose and Manage Conflicts of Interest at Cancer Centers. Jama Internal Medicine. 180: 161. PMID 31904783 DOI: 10.1001/Jamainternmed.2019.5542 |
0.353 |
|
| 2020 |
Taylor JA, Wood R, Ham T, Casey C, Dandawate P, Reed G, Woolbright BL, Baltezor MJ, Jensen RA, Dalton M, Zhukova-Harrill V, McCulloch W, Anant S, Weir SJ. Window of opportunity trial to characterize the safety, pharmacokinetics, and pharmacodynamics of fosciclopirox (CPX-POM) in cisplatin-ineligible muscle invasive bladder cancer patients. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.6_Suppl.Tps604 |
0.316 |
|
| 2020 |
Patel MR, Ulahannan SV, Weir SJ, Wood R, Ham T, Casey C, Reed G, Dandawate P, Ramamoorthy P, Baltezor MJ, Jensen RA, Woolbright BL, Taylor JA, Anant S, Dalton M, et al. Safety, dose tolerance, pharmacokinetics, and pharmacodynamics of fosciclopirox (CPX-POM) in patients with advanced solid tumors. Journal of Clinical Oncology. 38: 518-518. DOI: 10.1200/Jco.2020.38.6_Suppl.518 |
0.315 |
|
| 2020 |
Weir SJ, Dandawate P, Ramamoorthy P, Ranjarajan P, Wood R, Brinker A, Woolbright B, Tanol M, Ham T, McCulloch W, Dalton M, Baltezor MJ, Jensen RA, Taylor JA, Anant S. Abstract 6405: Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting Notch signaling Cancer Research. 80: 6405-6405. DOI: 10.1158/1538-7445.Am2020-6405 |
0.436 |
|
| 2020 |
Sayed A, Choudhury S, Subramaniam D, Gunewardena S, Ponnurangam S, Dandawate P, Umar S, Jensen R, Thomas S, Anant S. RNA Binding Protein RBM3 Modulates Novel LncRNAs to Increase Tumor Progression in Colon Cancer Cells The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.07588 |
0.357 |
|
| 2019 |
Dandawate P, Kaushik G, Ghosh C, Standing D, Sayed AAA, Choudhury S, Subramaniam D, Manzardo A, Banerjee T, Santra S, Ramamoorthy P, Butler M, Padhye SB, Baranda J, Kasi A, ... ... Jensen RA, et al. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice. Gastroenterology. PMID 31786131 DOI: 10.1053/J.Gastro.2019.11.279 |
0.321 |
|
| 2019 |
Dandawate P, Ghosh C, Palaniyandi K, Paul S, Rawal S, Pradhan R, Ali Sayed AA, Choudhury S, Standing D, Subramaniam D, Padhye S, Gunewardena S, Thomas SM, Neil MO, Tawfik O, ... ... Jensen RA, et al. The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 in and Promotes Tumorigenesis in Mice. Gastroenterology. PMID 31442435 DOI: 10.1053/J.Gastro.2019.08.018 |
0.376 |
|
| 2019 |
Weir SJ, Wood R, Schorno K, Brinker AE, Ramamoorthy P, Heppert K, Rajewski L, Tanol M, Ham T, McKenna MJ, McCulloch W, Dalton M, Reed GA, Jensen RA, Baltezor MJ, et al. Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment for Urothelial Cancers in Rats and Dogs. The Journal of Pharmacology and Experimental Therapeutics. PMID 31113837 DOI: 10.1124/Jpet.119.257972 |
0.312 |
|
| 2019 |
New J, Subramaniam D, Ramalingam S, Enders J, Sayed AAA, Ponnurangam S, Standing D, Ramamoorthy P, O'Neil M, Dixon DA, Saha S, Umar S, Gunewardena S, Jensen RA, Thomas SM, et al. Pleotropic role of RNA binding protein CELF2 in autophagy induction. Molecular Carcinogenesis. PMID 31020708 DOI: 10.1002/Mc.23023 |
0.343 |
|
| 2019 |
Li D, Harlan-Williams LM, Kumaraswamy E, Jensen RA. BRCA1-No Matter How You Splice It. Cancer Research. PMID 30992324 DOI: 10.1158/0008-5472.Can-18-3190 |
0.469 |
|
| 2019 |
Ramamoorthy P, Thomas SM, Kaushik G, Subramaniam D, Chastain KM, Dhar A, Tawfik O, Kasi A, Sun W, Ramalingam S, Gunewardena S, Umar S, Mammen JMV, Padhye SB, Weir SJ, ... Jensen RA, et al. Metastatic Tumor-In-A-Dish, A Novel Multi-Cellular Organoid to Study Lung Colonization and Predict Therapeutic Response. Cancer Research. PMID 30674533 DOI: 10.1158/0008-5472.Can-18-2602 |
0.381 |
|
| 2019 |
Vekaria PH, Kumar A, Subramaniam D, Dunavin N, Vallurupalli A, Schoenen F, Ganguly S, Anant S, McGuirk JP, Jensen RA, Rao R. Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells. Leukemia. PMID 30664664 DOI: 10.1038/S41375-018-0355-Y |
0.331 |
|
| 2019 |
Weir SJ, Wood R, Baltezor MJ, Reed G, Brinker AE, Ham T, Schorno K, Toren P, Ramamoorthy P, Zhukova-Harrill V, Dalton M, McCulloch W, Patel MR, Ulahannan SV, Burris HA, ... ... Jensen RA, et al. Pharmacokinetics of ciclopirox prodrug, a novel agent for the treatment of bladder cancer, in animals and humans. Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E14705 |
0.33 |
|
| 2019 |
Sharma P, Kimler BF, O'Dea A, Nye LE, Wang YY, Yoder R, Prochaska LH, Wagner JL, Amin AL, Larson K, Balanoff C, Elia M, Crane GJ, Madhusudhana S, Hoffmann MS, ... ... Jensen RA, et al. Results of randomized phase II trial of neoadjuvant carboplatin plus docetaxel or carboplatin plus paclitaxel followed by AC in stage I-III triple-negative breast cancer (NCT02413320). Journal of Clinical Oncology. 37: 516-516. DOI: 10.1200/Jco.2019.37.15_Suppl.516 |
0.366 |
|
| 2018 |
Ganguly S, Kuravi S, Alleboina S, Mudduluru G, Jensen RA, McGuirk JP, Balusu R. Targeted Therapy for EBV-associated B-cell Neoplasms. Molecular Cancer Research : McR. PMID 30487243 DOI: 10.1158/1541-7786.Mcr-18-0924 |
0.307 |
|
| 2018 |
Sharma P, López-Tarruella S, Garcia-Saenz JA, Khan QJ, Gomez H, Prat A, Moreno F, Jerez-Gilarranz Y, Barnadas A, Picornell AC, Del Monte-Millán M, Gonzalez-Rivera M, Massarrah T, Pelaez-Lorenzo B, Palomero MI, ... ... Jensen RA, et al. Pathological response and survival in triple-negative breast cancer following neoadjuvant carboplatin plus docetaxel. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30061361 DOI: 10.1158/1078-0432.Ccr-18-0585 |
0.367 |
|
| 2018 |
Li LX, Zhou JX, Calvet JP, Godwin AK, Jensen RA, Li X. Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression. Cell Death & Disease. 9: 326. PMID 29487338 DOI: 10.1038/S41419-018-0347-X |
0.49 |
|
| 2018 |
Mina A, Lehn C, Wang Y, Klemp J, O'Dea A, Elia M, Hoffmann M, Crane G, Sheehan M, Madhusudhana S, Jensen R, Godwin A, Khan Q, Kimler B, Sharma P. Abstract P4-10-06: Influence of older age on triple negative breast cancer (TNBC) clinical-pathological characteristics and outcomes Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P4-10-06 |
0.407 |
|
| 2018 |
Weir SJ, Ranjarajan P, Wood R, Schorno K, Ramamoorthy P, Rajweski L, Heppert K, McKenna MJ, McCulloch W, Reed GA, Brinker A, Baltezor MJ, Jensen RA, Taylor JA, Anant S. Abstract 5882: Bench-to-bedside translation of ciclopirox prodrug for the treatment of non-muscle invasive and muscle-invasive bladder cancer Cancer Research. 78: 5882-5882. DOI: 10.1158/1538-7445.Am2018-5882 |
0.411 |
|
| 2018 |
Subramaniam D, Ponnurangam S, Dandawate P, Tawfik O, Jensen RA, Santra S, Padhye S, Weir SJ, Anant S. 732 - Novel Marmelin Analog MRL16 Targets Notch Signaling Pathway in Colon Cancer Stem Cells Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)30922-3 |
0.375 |
|
| 2018 |
Sayed AAA, Subramaniam D, Gunewardena S, Ponnurangam S, Choudhury S, Enders J, Jensen RA, Thomas SM, Umar S, Anant S. 520 - RBM3 Increases Tumor Progression by Increasing Stemness and Metastasis in Colon Cancer Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)30819-9 |
0.393 |
|
| 2017 |
Kunchala P, Kuravi S, Jensen R, McGuirk J, Balusu R. When the good go bad: Mutant NPM1 in acute myeloid leukemia. Blood Reviews. 32: 167-183. PMID 29157973 DOI: 10.1016/J.Blre.2017.11.001 |
0.302 |
|
| 2017 |
Ryan R, Tawfik O, Jensen RA, Anant S. Current Approaches to Diagnosis and Treatment of Ductal Carcinoma In Situ and Future Directions. Progress in Molecular Biology and Translational Science. 151: 33-80. PMID 29096897 DOI: 10.1016/Bs.Pmbts.2017.08.001 |
0.316 |
|
| 2017 |
Valdez K, Ramamoorthy P, Anant S, Jensen R. Abstract B36: Targeting BRCA1 through natural HSP90 inhibitors to reverse platinum resistance in TNBC Molecular Cancer Research. 15. DOI: 10.1158/1557-3125.Dnarepair16-B36 |
0.512 |
|
| 2017 |
Prochaska L, Godwin A, Kimler B, Lehn C, Klemp J, O'Dea A, Elia M, Hoffmann, Crane G, McKittrick R, Sheehan M, Graff S, Madhusudhana S, Khan Q, Jensen R, et al. Abstract P5-16-02: Pathological complete response is associated with excellent outcomes inBRCAmutation associated triple negative breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P5-16-02 |
0.435 |
|
| 2017 |
Subramaniam D, Ponnurangam S, Dandawate PR, Kaushik G, Tawfik OW, Jensen RA, Santra S, Padhye SB, Weir SJ, Anant S. Abstract 3227: Novel Marmelin analog DBQ targets Notch signaling pathway in colon cancer stem cells Cancer Research. 77: 3227-3227. DOI: 10.1158/1538-7445.Am2017-3227 |
0.449 |
|
| 2017 |
Dandawate P, Fnu G, Subramaniam D, Ramamoorthy P, Paul S, Dhar A, Thomas SM, Santra S, Tawfik O, Weir SJ, Jensen RA, Anant S. Repurposing Penfluridol: An Old Antipsychotic Drug that Therapeutically Targets Prolactin Receptor in Pancreatic Cancer Gastroenterology. 152. DOI: 10.1016/S0016-5085(17)30800-4 |
0.329 |
|
| 2017 |
Anant S, Ramamoorthy P, Tawfik O, Jensen RA. Effects of Hsp90 Inhibitors on Patient Derived Triple Negative Breast Cancer (TNBC) Cells: BRCA1 as a Therapeutic Target for TNBC Journal of the American College of Surgeons. 225. DOI: 10.1016/J.Jamcollsurg.2017.07.536 |
0.491 |
|
| 2016 |
Mackay CB, Gurley-Calvez T, Erickson KD, Jensen RA. Clinical trial insurance coverage for cancer patients under the Affordable Care Act. Contemporary Clinical Trials Communications. 2: 69-74. PMID 29736447 DOI: 10.1016/J.Conctc.2015.12.002 |
0.326 |
|
| 2016 |
Dandawate PR, Subramaniam D, Jensen RA, Anant S. Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy. Seminars in Cancer Biology. PMID 27609747 DOI: 10.1016/J.Semcancer.2016.09.001 |
0.529 |
|
| 2016 |
Sharma P, López-Tarruella S, García-Saenz JA, Ward C, Connor C, Gómez HL, Prat A, Moreno F, Jerez-Gilarranz Y, Barnadas A, Picornell A, Del Monte-Millán M, Gonzalez-Rivera M, Massarrah T, Pelaez-Lorenzo B, ... ... Jensen RA, et al. Efficacy of neoadjuvant carboplatin plus docetaxel in triple negative breast cancer: Combined analysis of two cohorts. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27301700 DOI: 10.1158/1078-0432.Ccr-16-0162 |
0.472 |
|
| 2016 |
Sharma P, Kimler BF, Ward C, O'Dea A, Hoffmann MS, Klemp JR, McGinness M, Wagner JL, Mammen J, Amin AL, Lehn C, Jensen RA, Godwin AK, Khan QJ. Prognosis of triple negative breast cancer patients who attain pathological complete response with neoadjuvant carboplatin/docetaxel and do not receive adjuvant anthracycline chemotherapy. Journal of Clinical Oncology. 34: 1015-1015. DOI: 10.1200/Jco.2016.34.15_Suppl.1015 |
0.428 |
|
| 2016 |
Subramaniam D, Ponnurangam S, Dandawate PR, Tawfik OW, Jensen RA, Weir SJ, Padhye SB, Anant S. Abstract 4748: Targeting colon cancer stem cells: Novel marmelin analog THB suppresses DCLK1 and Notch Signaling Cancer Research. 76: 4748-4748. DOI: 10.1158/1538-7445.Am2016-4748 |
0.443 |
|
| 2016 |
Ramamoorthy P, Rangarajan P, Tawfik O, Anant S, Jensen RA. Abstract 4632: Effects of Hsp90 inhibitors on triple-negative breast cancer: BRCA1 as a therapeutic target for TNBC Cancer Research. 76: 4632-4632. DOI: 10.1158/1538-7445.Am2016-4632 |
0.512 |
|
| 2016 |
Valdez KE, Ramamoorthy P, Anant S, Jensen R. Abstract 3832: Combination use of natural Hsp90 inhibitors to reverse BRCA1-mediated platinum resistance in triple negative breast cancer Cancer Research. 76: 3832-3832. DOI: 10.1158/1538-7445.Am2016-3832 |
0.532 |
|
| 2016 |
Ramamoorthy P, Rangarajan P, Jensen R, Anant S. Abstract 3314: Targeting Hsp90 affects stem cell signaling in triple negative breast cancer Cancer Research. 76: 3314-3314. DOI: 10.1158/1538-7445.Am2016-3314 |
0.51 |
|
| 2016 |
Subramaniam D, Ponnurangam S, Fnu G, Ramamoorthy P, Dhar A, Tawfik OW, Umar S, Weir SJ, Jensen RA, Balakrishnan A, Anant S. Abstract 1727: Quinomycin A inhibits pancreatic cancer growth and affects stem cell viability by inhibiting oncogenic YAP1 function Cancer Research. 76: 1727-1727. DOI: 10.1158/1538-7445.Am2016-1727 |
0.433 |
|
| 2016 |
Dandawate P, Kaushik G, Subramaniam D, Ramamoorthy P, Weir SJ, Jensen RA, Anant S. Abstract 1310: Targetingprolactin signaling to suppress pancreatic cancer stem cells Cancer Research. 76: 1310-1310. DOI: 10.1158/1538-7445.Am2016-1310 |
0.435 |
|
| 2016 |
Subramaniam D, Ponnurangam S, Fnu G, Ramamoorthy P, Tawfik O, Weir SJ, Umar S, Jensen RA, Anant S. 470 Targeting c-KIT Suppresses Hippo Signaling in Colon Cancer Stem Cells Gastroenterology. 150. DOI: 10.1016/S0016-5085(16)30455-3 |
0.372 |
|
| 2015 |
Ponnurangam S, Dandawate PR, Dhar A, Tawfik OW, Parab RR, Mishra PD, Ranadive P, Sharma R, Mahajan G, Umar S, Weir SJ, Sugumar A, Jensen RA, Padhye SB, Balakrishnan A, et al. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells. Oncotarget. PMID 26673007 DOI: 10.18632/Oncotarget.6560 |
0.424 |
|
| 2015 |
Welch DR, Antalis TM, Burnstein K, Vona-Davis L, Jensen RA, Nakshatri H, Riegel AT, Spitz DR, Watson DK, Weiner GJ. Essential Components of Cancer Education. Cancer Research. PMID 26627010 DOI: 10.1158/0008-5472.Can-15-2077 |
0.327 |
|
| 2015 |
Baselga J, Bhardwaj N, Cantley LC, DeMatteo R, DuBois RN, Foti M, Gapstur SM, Hahn WC, Helman LJ, Jensen RA, Paskett ED, Lawrence TS, Lutzker SG, Szabo E. AACR Cancer Progress Report 2015. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: S1-S128. PMID 26429991 DOI: 10.1158/1078-0432.Ccr-15-1846 |
0.41 |
|
| 2015 |
Home T, Jensen RA, Rao R. Heat shock factor 1 in protein homeostasis and oncogenic signal integration. Cancer Research. 75: 907-12. PMID 25724679 DOI: 10.1158/0008-5472.Can-14-2905 |
0.316 |
|
| 2015 |
Kumaraswamy E, Wendt KL, Augustine LA, Stecklein SR, Sibala EC, Li D, Gunewardena S, Jensen RA. BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function. Oncogene. 34: 4333-46. PMID 25417703 DOI: 10.1038/Onc.2014.363 |
0.689 |
|
| 2015 |
Sharma P, Kimler BF, Klemp JR, Ward C, Connor CS, McGinness M, Mammen JMV, Wagner JL, Amin AL, Fabian CJ, Jensen RA, Godwin AK, Khan QJ. Outcomes with neoadjuvant versus adjuvant chemotherapy for T1-2 node negative triple negative breast cancer. Journal of Clinical Oncology. 33: 1092-1092. DOI: 10.1200/Jco.2015.33.15_Suppl.1092 |
0.417 |
|
| 2015 |
Sharma P, Powers BC, Kimler BF, Ward C, Klemp JR, Connor CS, McGinness MK, Mammen JM, Wagner JL, Khan QJ, Jensen RA, Godwin AK, Fabian CJ. Abstract P3-06-16: Thrombocytopenia is associated with pathological complete response to neoadjuvant carboplatin/docetaxel chemotherapy inBRCAwild type triple negative breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P3-06-16 |
0.489 |
|
| 2015 |
Subramaniam D, Ponnurangam S, Sayed A, Dhar A, Dixon DA, Tawfik O, Parab RR, Mishra PD, Ranadive P, Sharma R, Mahajan G, Sugumar A, Weir SJ, Jensen RA, Balakrishnan A, et al. Abstract 4214: Quinomycin A affects pancreatic cancer stem cells in part through suppression of notch signaling pathway Cancer Research. 75: 4214-4214. DOI: 10.1158/1538-7445.Am2015-4214 |
0.422 |
|
| 2015 |
Subramaniam D, Ponnurangam S, Kwatra D, Kaushik G, Ramamoorthy P, Ramalingam S, Tawfik O, Weir SJ, Padhye S, Dixon DA, Umar S, Jensen RA, Anant S. Abstract 1893: Honokiol prevents colonic tumorigenesis and affects stem cell viability by affecting oncogenic YAP1 function Cancer Research. 75: 1893-1893. DOI: 10.1158/1538-7445.Am2015-1893 |
0.407 |
|
| 2015 |
Ramamoorthy P, Ramalingam S, Subramaniam D, Dandawate P, Tawfik O, Jensen RA, Baranda JC, Weir SJ, Olyaee MS, Padhye S, Sittampalam GS, Anant S. 293 A Novel “Tumor in a Dish” Method to Study Primary and Metastatic Colon Cancer; Differential Therapeutic Responses in Cancers With Mismatch Repair Defects Gastroenterology. 148. DOI: 10.1016/S0016-5085(15)30222-5 |
0.434 |
|
| 2014 |
Kaushik G, Venugopal A, Ramamoorthy P, Standing D, Subramaniam D, Umar S, Jensen RA, Anant S, Mammen JM. Honokiol inhibits melanoma stem cells by targeting notch signaling. Molecular Carcinogenesis. PMID 25491779 DOI: 10.1002/Mc.22242 |
0.341 |
|
| 2014 |
Kaushik G, Kwatra D, Subramaniam D, Jensen RA, Anant S, Mammen JM. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway. American Journal of Surgery. 208: 995-1002; discussion. PMID 25450590 DOI: 10.1016/J.Amjsurg.2014.09.014 |
0.398 |
|
| 2014 |
Sharma P, Stecklein SR, Kimler BF, Sethi G, Petroff BK, Phillips TA, Tawfik OW, Godwin AK, Jensen RA. The prognostic value of BRCA1 promoter methylation in early stage triple negative breast cancer. Journal of Cancer Therapeutics & Research. 3: 1-11. PMID 25177489 DOI: 10.7243/2049-7962-3-2 |
0.691 |
|
| 2014 |
Sharma P, Klemp JR, Kimler BF, Mahnken JD, Geier LJ, Khan QJ, Elia M, Connor CS, McGinness MK, Mammen JM, Wagner JL, Ward C, Ranallo L, Knight CJ, Stecklein SR, ... Jensen RA, et al. Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing. Breast Cancer Research and Treatment. 145: 707-14. PMID 24807107 DOI: 10.1007/S10549-014-2980-0 |
0.689 |
|
| 2014 |
Paul A, Gunewardena S, Stecklein SR, Saha B, Parelkar N, Danley M, Rajendran G, Home P, Ray S, Jokar I, Vielhauer GA, Jensen RA, Tawfik O, Paul S. PKCλ/ι signaling promotes triple-negative breast cancer growth and metastasis. Cell Death and Differentiation. 21: 1469-81. PMID 24786829 DOI: 10.1038/Cdd.2014.62 |
0.737 |
|
| 2014 |
Neradugomma NK, Subramaniam D, Tawfik OW, Goffin V, Kumar TR, Jensen RA, Anant S. Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner. Carcinogenesis. 35: 795-806. PMID 24265293 DOI: 10.1093/Carcin/Bgt379 |
0.395 |
|
| 2014 |
Sharma P, Stecklein SR, Kimler BF, Khan QJ, Connor CS, McGinness M, Mammen J, Wagner JL, Jensen RA, Godwin AK, Fabian CJ. Efficacy of neoadjuvant carboplatin/docetaxel chemotherapy in sporadic and BRCA-associated triple-negative breast cancer (TNBC). Journal of Clinical Oncology. 32: 1022-1022. DOI: 10.1200/Jco.2014.32.15_Suppl.1022 |
0.718 |
|
| 2014 |
Stecklein SR, Jensen RA. Breast cancer stem cells Stem Cells and Human Diseases. 451-465. DOI: 10.1007/978-94-007-2801-1_20 |
0.699 |
|
| 2013 |
Li D, Kumaraswamy E, Harlan-Williams LM, Jensen RA. The role of BRCA1 and BRCA2 in prostate cancer. Frontiers in Bioscience (Landmark Edition). 18: 1445-59. PMID 23747895 DOI: 10.2741/4191 |
0.42 |
|
| 2013 |
Ramamoorthy P, Byrne S, Ramalingam S, Rangarajan P, Subramaniam D, Weir S, Anant S, Jensen R. Abstract PR05: Effects of Hsp90 inhibitors on triple-negative breast cancer: Notch as a therapeutic target for stem cells Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-Pr05 |
0.521 |
|
| 2013 |
Rangarajan P, Ramamoorthy P, Ramalingam S, Subramaniam D, Ponnurangam S, Weir S, Anant S, Jensen R. Abstract B32: Gedunin induces autophagy during mitosis, a novel form of mitotic catastrophe Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-B32 |
0.522 |
|
| 2013 |
Subramaniam D, Ponnurangam S, Umar S, Ramalingam S, Jensen RA, Anant S. Abstract 3662: Honokiol affects stem cell viability in part through suppression of Hippo signaling pathway. Cancer Research. 73: 3662-3662. DOI: 10.1158/1538-7445.Am2013-3662 |
0.432 |
|
| 2012 |
Stecklein SR, Kumaraswamy E, Behbod F, Wang W, Chaguturu V, Harlan-Williams LM, Jensen RA. BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation. Proceedings of the National Academy of Sciences of the United States of America. 109: 13650-5. PMID 22869732 DOI: 10.1073/Pnas.1203326109 |
0.784 |
|
| 2012 |
Stecklein SR, Jensen RA. Identifying and exploiting defects in the Fanconi anemia/BRCA pathway in oncology. Translational Research : the Journal of Laboratory and Clinical Medicine. 160: 178-97. PMID 22683426 DOI: 10.1016/J.Trsl.2012.01.022 |
0.714 |
|
| 2012 |
Stecklein SR, Jensen RA, Pal A. Genetic and epigenetic signatures of breast cancer subtypes. Frontiers in Bioscience (Elite Edition). 4: 934-49. PMID 22201926 |
0.706 |
|
| 2012 |
Sharma P, Stecklein S, Kimler B, Klemp J, Khan Q, Fabian C, Tawfik O, Connor C, McGinness M, Mammen J, Jensen R. Abstract PD09-02: BRCA1 insufficiency is predictive of superior survival in patients with triple negative breast cancer treated with platinum based chemotherapy Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-Pd09-02 |
0.724 |
|
| 2011 |
Sharma P, Kimler BF, Park YA, Stecklein SR, Khan QJ, Petroff BK, Tawfik OW, Jensen RA. Association of BRCA1 promoter methylation in triple-negative breast cancer (TNBC) with resistance to standard anthracyline-based adjuvant chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1123. PMID 28021523 DOI: 10.1200/Jco.2011.29.15_Suppl.1123 |
0.713 |
|
| 2011 |
Subramaniam D, Nicholes ND, Dhar A, Umar S, Awasthi V, Welch DR, Jensen RA, Anant S. 3,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesis. Molecular Cancer Therapeutics. 10: 2146-56. PMID 21890747 DOI: 10.1158/1535-7163.Mct-11-0399 |
0.423 |
|
| 2011 |
Subramaniam D, Ramalingam S, Linehan DC, Dieckgraefe BK, Postier RG, Houchen CW, Jensen RA, Anant S. RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells. Plos One. 6: e16958. PMID 21347286 DOI: 10.1371/Journal.Pone.0016958 |
0.349 |
|
| 2011 |
Subramaniam D, Awasthi V, Houchen CW, Jensen RA, Anant S. Abstract 5417: A novel curcumin derivative DiFiD prevents pancreatic cancer growthin vivoby suppressing Notch-1 Cancer Research. 71: 5417-5417. DOI: 10.1158/1538-7445.Am2011-5417 |
0.417 |
|
| 2011 |
Ramalingam S, Subramaniam D, Jensen RA, Anant S. Abstract 4362: RBM3 overexpression promotes cancer stem cell expansion through activation of Notch-1 signaling Cancer Research. 71: 4362-4362. DOI: 10.1158/1538-7445.Am2011-4362 |
0.404 |
|
| 2011 |
Venugopal A, Ramalingam S, Subramaniam D, He Z, Jensen R, Anant S. Abstract 3080: Novel splicing activity for RNA binding protein CUGBP2 in radiation-induced mitotic catastrophe Cancer Research. 71: 3080-3080. DOI: 10.1158/1538-7445.Am2011-3080 |
0.338 |
|
| 2011 |
Kumaraswamy E, Stecklein SR, Augustine LA, Jensen RA. Abstract 1188: BRCA1 regulates EGFR expression through microRNAs Cancer Research. 71: 1188-1188. DOI: 10.1158/1538-7445.Am2011-1188 |
0.702 |
|
| 2011 |
Jensen RA, Harlan-Williams LM, Wang W, Stecklein SR. Basic cancer biology and immunology Principles and Practice of Fertility Preservation. 35-48. DOI: 10.1017/CBO9780511921896.007 |
0.67 |
|
| 2010 |
Harlan-Williams LM, Overton JA, Stecklein SR, Wang W, Jensen RA. Abstract 757: Identification and characterization of small molecule activators of BRCA1 expression Cancer Research. 70: 757-757. DOI: 10.1158/1538-7445.Am10-757 |
0.74 |
|
| 2010 |
Wang W, Harlan-Williams LM, Jensen RA. Abstract 494: Identification and characterization of novel kinases that regulate BRCA1 expression and function Cancer Research. 70: 494-494. DOI: 10.1158/1538-7445.Am10-494 |
0.462 |
|
| 2010 |
Stecklein SR, Harlan-Williams LM, Wang W, Eskew JD, Chaguturu V, Jensen RA. Abstract 1391: Inhibition of Hsp90 induces BRCA1 degradation and hypersensitivity to ionizing radiation Cancer Research. 70: 1391-1391. DOI: 10.1158/1538-7445.Am10-1391 |
0.736 |
|
| 2008 |
Rizki A, Weaver VM, Lee SY, Rozenberg GI, Chin K, Myers CA, Bascom JL, Mott JD, Semeiks JR, Grate LR, Mian IS, Borowsky AD, Jensen RA, Idowu MO, Chen F, et al. A human breast cell model of preinvasive to invasive transition. Cancer Research. 68: 1378-87. PMID 18316601 DOI: 10.1158/0008-5472.Can-07-2225 |
0.39 |
|
| 2006 |
McLaren BK, Schuyler PA, Sanders ME, Jensen RA, Simpson JF, Dupont WD, Page DL. Excellent survival, cancer type, and Nottingham grade after atypical lobular hyperplasia on initial breast biopsy. Cancer. 107: 1227-33. PMID 16894523 DOI: 10.1002/cncr.22113 |
0.35 |
|
| 2003 |
Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD, Simpson JF. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet (London, England). 361: 125-9. PMID 12531579 DOI: 10.1016/S0140-6736(03)12230-1 |
0.348 |
|
| 2001 |
Gobbi H, Jensen RA, Simpson JF, Olson SJ, Page DL. Atypical ductal hyperplasia and ductal carcinoma in situ of the breast associated with perineural invasion. Human Pathology. 32: 785-90. PMID 11521220 DOI: 10.1053/Hupa.2001.27637 |
0.303 |
|
| 2001 |
Campbell M, Aprelikova ON, van der Meer R, Woltjer RL, Yee CJ, Liu ET, Jensen RA. Construction and characterization of recombinant adenoviruses expressing human BRCA1 or murine Brca1 genes. Cancer Gene Therapy. 8: 231-9. PMID 11332994 DOI: 10.1038/Sj.Cgt.7700291 |
0.314 |
|
| 2000 |
Robinson-Benion C, Jensen RA, Holt JT. Analysis of cancer gene functions through gene inhibition with antisense oligonucleotides. Methods in Enzymology. 314: 499-506. PMID 10565035 DOI: 10.1016/S0076-6879(99)14125-9 |
0.44 |
|
| 1999 |
Aprelikova ON, Fang BS, Meissner EG, Cotter S, Campbell M, Kuthiala A, Bessho M, Jensen RA, Liu ET. BRCA1-associated growth arrest is RB-dependent. Proceedings of the National Academy of Sciences of the United States of America. 96: 11866-71. PMID 10518542 DOI: 10.1073/Pnas.96.21.11866 |
0.415 |
|
| 1999 |
Abbott DW, Thompson ME, Robinson-Benion C, Tomlinson G, Jensen RA, Holt JT. BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. The Journal of Biological Chemistry. 274: 18808-12. PMID 10373498 DOI: 10.1074/JBC.274.26.18808 |
0.372 |
|
| 1998 |
Tait DL, Jensen RA, Holt JT, Johnson DH, Gralow J, King MC. Gene therapy for breast and ovarian cancer with BRCA1. Breast Disease. 10: 89-98. PMID 15687552 DOI: 10.3233/Bd-1998-101-211 |
0.391 |
|
| 1998 |
Kasami M, Vnencak-Jones CL, Manning S, Dupont WD, Jensen RA, Page DL. Monoclonality in fibroadenomas with complex histology and phyllodal features. Breast Cancer Research and Treatment. 50: 185-191. PMID 9822223 DOI: 10.1023/A:1006050208157 |
0.356 |
|
| 1997 |
Page DL, Jensen RA. Genetic Testing and Informed Consent Jama. 278: 821-821. PMID 9293987 DOI: 10.1001/Jama.278.10.821 |
0.368 |
|
| 1996 |
Page DL, Salhany KE, Jensen RA, Dupont WD. Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma. Cancer. 78: 258-66. PMID 8674001 DOI: 10.1002/(SICI)1097-0142(19960715)78:2<258::AID-CNCR11>3.0.CO;2-V |
0.303 |
|
| 1996 |
Page DL, Jensen RA. Ductal carcinoma in situ of the breast: Understanding the misunderstood stepchild Journal of the American Medical Association. 275: 948-949. PMID 8598624 DOI: 10.1001/Jama.1996.03530360058039 |
0.382 |
|
| 1996 |
Holt JT, Thompson ME, Szabo C, Robinson-Benion C, Arteaga CL, King MC, Jensen RA. Growth retardation and tumour inhibition by BRCA1. Nature Genetics. 12: 298-302. PMID 8589721 DOI: 10.1038/Ng0396-298 |
0.401 |
|
| 1996 |
Page DL, Kasami M, Jensen RA. Hypersecretory Hyperplasia With Atypia in Breast Biopsies: What is the Proper Level of Clinical Concern? Pathology Case Reviews. 1: 36-40. DOI: 10.1097/00132583-199605000-00011 |
0.368 |
|
| 1996 |
Page DL, Jensen RA. Detection and Treatment of Ductal Carcinoma In Situ of the Breast-Reply Jama. 276: 871-871. DOI: 10.1001/Jama.1996.03540110025019 |
0.369 |
|
| 1995 |
Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genetics. 9: 444-50. PMID 7795653 DOI: 10.1038/ng0495-444 |
0.431 |
|
| 1995 |
Page DL, Jensen RA. Angiogenesis in human breast carcinoma: What is the question? Human Pathology. 26: 1173-1174. PMID 7590687 DOI: 10.1016/0046-8177(95)90188-4 |
0.359 |
|
| 1994 |
Caleffi M, Teague MW, Jensen RA, Vnencak-Jones CL, Dupont WD, Parl FF. p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment. Cancer. 73: 2147-56. PMID 8156519 DOI: 10.1002/1097-0142(19940415)73:8<2147::AID-CNCR2820730820>3.0.CO;2-5 |
0.329 |
|
| 1994 |
Jensen RA, Page DL, Holt JT. Identification of genes expressed in premalignant breast disease by microscopy-directed cloning. Proceedings of the National Academy of Sciences of the United States of America. 91: 9257-61. PMID 7937751 DOI: 10.1073/pnas.91.20.9257 |
0.324 |
|
| Show low-probability matches. |